Hopeful antioxidant tested to slow blinding eye disease
NCT ID NCT03999021
Summary
This study is checking the long-term safety and side effects of a high-dose antioxidant supplement called N-Acetylcysteine (NAC) in 30 adults with retinitis pigmentosa, a disease that damages vision. The goal is to see if people can safely take this medication twice daily for an extended period, as it is thought to protect delicate eye cells from damage. This is an early-phase study focused on safety, not proving if the treatment works to save vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wilmer Eye Institute at Johns Hopkins University
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.